On August 26, 2025, Enveric Biosciences, Inc. received a notice from Nasdaq stating it does not meet the minimum stockholders’ equity requirement of $2,500,000, reporting only $2,184,769 as of June 30, 2025. The company has until October 10, 2025, to submit a plan to regain compliance or face potential delisting.